NCT04458922 2026-03-17Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced ChondrosarcomaNational Cancer Institute (NCI)Phase 2 Active not recruiting27 enrolled 16 charts
NCT06712810 2025-10-10Q702 for the Treatment of Patients With Hematologic MalignanciesMayo ClinicPhase 1 Recruiting46 enrolled